Technical analysis of AbCellera Biologics Inc. (ABCL): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities.
Price Performance
| 1 month | -19.07% |
| 3 months | +87.84% |
| Year-to-date | +225.15% |
| 1 year | +107.08% |
| 3 years | +136.60% |
| 5 years | -35.98% |
52-Week Range
| 52-week High | $15.02 |
| 52-week Low | $2.75 |
| Avg Volume (90d) | 6.4M |
Technical Indicators
| SMA 50 | $12.28 |
| SMA 200 | $6.89 |
| Beta | 0.85 |
| 30-day Volatility (annualised) | 73.2% |
| Price vs SMA 50 | -9.5% |
| Price vs SMA 200 | +61.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $3.42 | |
| 2026-01 | $3.62 | +5.8% |
| 2026-02 | $3.61 | -0.3% |
| 2026-03 | $3.49 | -3.3% |
| 2026-04 | $4.15 | +18.9% |
| 2026-05 | $6.17 | +48.7% |
| 2026-06 | $7.85 | +27.2% |
| 2026-07 | $5.71 | -27.3% |
| 2026-08 | $11.48 | +101.1% |
| 2026-09 | $14.59 | +27.1% |
| 2026-10 | $12.27 | -15.9% |
| 2026-11 | $11.12 | -9.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-09 | $-0.17 | $8M |
| 2026-08-05 | $-0.16 | $8M |
| 2026-05-11 | $-0.22 | $5M |
| 2026-02-24 | $-0.18 | $7M |
| 2025-11-06 | $-0.17 | $6M |
| 2025-08-07 | $-0.17 | $6M |
| 2025-05-08 | $-0.17 | $7M |
Price
| Price | $11.12 (closing price, November 2, 2026) |
| Market Cap | $3.6B |
| Exchange | NASDAQ |
| Country | CA |
Valuation Ratios
| Price / Book | 3.79 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.15 |
| Current Ratio | 12.77 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 1.66 |